Edwards Comments on German Appellate Court Ruling
IRVINE, CA -- (Marketwired) -- 11/14/13 -- Edwards Lifesciences
Corporation (NYSE: EW), the global leader in the science of heart
valves and hemodynamic monitoring, today said that an appeals court
in Germany has suspended the enforcement of an injunction against
sales of Medtronic's transcatheter heart valves in Germany, pending
the posting of a EUR 5 million bond by Medtronic. This action comes
after the European Patent Office (EPO) issued a non-binding
preliminary opinion in October indicating concerns about the validity
of the Edwards Spenser patent.
About Edwards Lifesciences
Edwards Lifesciences is the global leader
in the science of heart valves and hemodynamic monitoring. Driven by
a passion to help patients, the company partners with clinicians to
develop innovative technologies in the areas of structural heart
disease and critical care monitoring, enabling them to save and
enhance lives. Additional company information can be found at
Edwards, Edwards Lifesciences, and the stylized E logo are trademarks
of Edwards Lifesciences Corporation.
David K. Erickson
Press spacebar to pause and continue. Press esc to stop.